After suicide gene-transduced MSC transplantation and GCV treatment, we found, by monitoring CT26/Rluc activity using BLI, that tumor growth was inhibited in the GCV+DOX-treated MSC-Tet-TK group (Figure 4A) compared to that in the DOX-only treatment group. Here, DDX53 is linked to neoplasm.